We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months--Selected U.S. Regions, 2010-2011.
- Authors
Harriman, Kathleen; Thomas, Tracy N.; Kolasa, Maureen; Cullen, Karen; Pabst, Laura; Shefer, Abigail; Cox, Chad; Moore, Matthew; Link-Gelles, Ruth
- Abstract
The article presents data on the prevalence of invasive pneumococcal disease (IPD) and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged 14 to 59 months in selected U.S. regions from May 1, 2010 to April 30, 2011. Evaluation of data from Active Bacterial Core surveillance revealed 135 cases of IPD caused by serotypes unique to PCV13. Thrity-seven percent of children with a complete PCV7 series received supplemental PCV13 dose. Children aged 24 through 59 months had lower coverage than children aged 12 through 23 months. PCV13 coverage reached 46 percent, out of the 700,000 children aged zero through 59 months, by June 30, 2010. Children aged 24 through 59 months were less likely to receive a PCV13 dose than younger children. INSET: What is already known on this topic?.
- Subjects
UNITED States; PNEUMOCOCCAL vaccines; IMMUNIZATION of children; DRUG dosage; PREVENTIVE medicine; SEROTYPES
- Publication
JAMA: Journal of the American Medical Association, 2011, Vol 306, Issue 22, p2449
- ISSN
0098-7484
- Publication type
Article